Johanna Mylet

Directeur Financier/CFO chez POSEIDA THERAPEUTICS, INC.

39 ans

Health Technology

Commercial Services

Consumer Services

Profil

Johanna M.
Mylet is currently the Chief Financial Officer at Poseida Therapeutics, Inc. She started this position in 2021.
Prior to her current role, she worked as a Controller at HUYA Bioscience International LLC from 2014 to 2015.
Before that, she served as an Audit Manager at Grant Thornton LLP from 2008 to 2014.
Ms. Mylet completed her undergraduate degree at the University of San Diego.

Postes actifs de Johanna Mylet

Sociétés	Poste	Début
POSEIDA THERAPEUTICS, INC.	Directeur Financier/CFO	01/07/2020

Tous les postes actifs de Johanna Mylet

Anciens postes connus de Johanna Mylet

Sociétés	Poste	Fin
Huyabio International LLC Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Comptroller/Controller/Auditor	01/06/2015
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Comptroller/Controller/Auditor	01/04/2014

Voir l'expérience en détail de Johanna Mylet

Formation de Johanna Mylet

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Johanna Mylet

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Huyabio International LLC Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
Grant Thornton LLP Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services	Commercial Services
University of San Diego University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics	Health Technology